rs564428355

Variant summary

Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PS3PM1PP2PP3_ModeratePP5_Very_Strong

The NM_000404.4(GLB1):​c.1325G>A​(p.Arg442Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000031 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000754700: Experimental studies have shown that this missense change affects GLB1 function (PMID:16314480, 18571950)." and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. R442R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000085 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

GLB1
NM_000404.4 missense

Scores

9
5
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:9

Conservation

PhyloP100: 5.65

Publications

15 publications found
Variant links:
Genes affected
GLB1 (HGNC:4298): (galactosidase beta 1) This gene encodes a member of the glycosyl hydrolase 35 family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature lysosomal enzyme. This enzyme catalyzes the hydrolysis of a terminal beta-linked galactose residue from ganglioside substrates and other glycoconjugates. Mutations in this gene may result in GM1-gangliosidosis and Morquio B syndrome. [provided by RefSeq, Nov 2015]
GLB1 Gene-Disease associations (from GenCC):
  • GM1 gangliosidosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
  • GM1 gangliosidosis type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • mucopolysaccharidosis type 4B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • GM1 gangliosidosis type 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • GM1 gangliosidosis type 2
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 17 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000754700: Experimental studies have shown that this missense change affects GLB1 function (PMID: 16314480, 18571950).; SCV001792786: Published functional studies demonstrate that p.(R344Q) seriously impairs enzymatic activity, measured in transiently transfected COS-1 cells (PMID: 16314480); SCV004047843: Experimental studies have shown that this missense change impairs enzymatic activity in vitro (Caciotti et al., 2009; Caciotti et al., 2005).; SCV005352190: This variant has been reported in the compound heterozygous state in individuals with GM1-Gangliosidosis and shown using in vitro studies to negatively affect enzymatic activity (Caciotti et al. 2005. PubMed ID: 16314480; Caciotti et al. 2009. PubMed ID: 18571950; Caciotti et al. 2011. PubMed ID: 21497194; Kumar et al. 2016. PubMed ID: 27679996).; SCV005849195: Experimental studies have shown that this missense change affects GLB1 function (Caciotti et al., 2005; Caciotti et al., 2009).
PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 4 uncertain in NM_000404.4
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 110 curated pathogenic missense variants (we use a threshold of 10). The gene has 24 curated benign missense variants. Gene score misZ: 0.79419 (below the threshold of 3.09). Trascript score misZ: 1.1264 (below the threshold of 3.09). GenCC associations: The gene is linked to mucopolysaccharidosis type 4B, GM1 gangliosidosis, GM1 gangliosidosis type 3, GM1 gangliosidosis type 2, GM1 gangliosidosis type 1.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.909
PP5
Variant 3-33018470-C-T is Pathogenic according to our data. Variant chr3-33018470-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 528328.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000404.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLB1
NM_000404.4
MANE Select
c.1325G>Ap.Arg442Gln
missense
Exon 13 of 16NP_000395.3
GLB1
NM_001317040.2
c.1469G>Ap.Arg490Gln
missense
Exon 14 of 17NP_001303969.2
GLB1
NM_001079811.3
c.1235G>Ap.Arg412Gln
missense
Exon 13 of 16NP_001073279.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLB1
ENST00000307363.10
TSL:1 MANE Select
c.1325G>Ap.Arg442Gln
missense
Exon 13 of 16ENSP00000306920.4P16278
GLB1
ENST00000307377.12
TSL:1
c.932G>Ap.Arg311Gln
missense
Exon 10 of 13ENSP00000305920.8E7EQ29
GLB1
ENST00000399402.7
TSL:2
c.1235G>Ap.Arg412Gln
missense
Exon 13 of 16ENSP00000382333.2P16278

Frequencies

GnomAD3 genomes
AF:
0.0000855
AC:
13
AN:
152034
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000459
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.0000561
AC:
14
AN:
249578
AF XY:
0.0000591
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000265
Gnomad OTH exome
AF:
0.000495
GnomAD4 exome
AF:
0.0000253
AC:
37
AN:
1461880
Hom.:
0
Cov.:
31
AF XY:
0.0000303
AC XY:
22
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000325
AC:
28
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000629
AC:
7
AN:
1112004
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000854
AC:
13
AN:
152152
Hom.:
0
Cov.:
31
AF XY:
0.0000941
AC XY:
7
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41508
American (AMR)
AF:
0.000458
AC:
7
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68002
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000105
Hom.:
0
Bravo
AF:
0.0000793
ExAC
AF:
0.0000910
AC:
11
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Mucopolysaccharidosis, MPS-IV-B;C0268271:Infantile GM1 gangliosidosis;C0268272:GM1 gangliosidosis type 2;C0268273:GM1 gangliosidosis type 3 (2)
2
-
-
not provided (2)
1
-
-
GLB1-related disorder (1)
1
-
-
GM1 gangliosidosis type 2 (1)
1
-
-
GM1 gangliosidosis type 3 (1)
1
-
-
GM1 gangliosidosis;C0086652:Mucopolysaccharidosis, MPS-IV-B (1)
1
-
-
Infantile GM1 gangliosidosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Pathogenic
0.30
D
BayesDel_noAF
Pathogenic
0.49
CADD
Pathogenic
26
DANN
Pathogenic
1.0
Eigen
Pathogenic
0.78
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.93
D
M_CAP
Pathogenic
0.30
D
MetaRNN
Pathogenic
0.91
D
MetaSVM
Pathogenic
1.1
D
PhyloP100
5.7
PrimateAI
Benign
0.37
T
PROVEAN
Uncertain
-3.6
D
REVEL
Pathogenic
0.86
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.027
D
Polyphen
1.0
D
Vest4
0.92
MutPred
0.76
Gain of glycosylation at Y444 (P = 0.0075)
MVP
0.97
MPC
0.93
ClinPred
0.96
D
GERP RS
5.3
gMVP
0.92
Mutation Taster
=5/95
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs564428355; hg19: chr3-33059962; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.